MTOR and neoplasm: Similarly, drugs did not impact on mTOR S2448, VEGFR2 Y996, pERK T202/Y204 and Cyclin D1 expression levels in tumor counterparts while Tensirolimus reduced cancer organoid capacity formation (Supplementary Fig. 15).